Title 5. DRUG INFORMATION AND POISONS INFORMATION.pdf ✅

PHARMD GURU Page 1 DRUG INFORMATION AND POISONS INFORMATION DRUG INFORMATION • It is the current, relevant, critically examined data about drug and drug use for given patient or situation. • Many institutes run DIC (Drug Information Centre) for the provision of drug information, to every group/kind of people from any place. HISTORY: • First DIC was developed in University of Kentucky in 1960. In United states 80% of the Hospitals having DIC. • INDIA, in infancy stage with a few centres. • In India beginning has been made by the professor of pharmacology Mumbai at a govt medical college. • CMC and Hospital Vellore have been trying in this direction earlier. NEED OF DRUG INFORMATION: 1. The no of drugs in the international market has increased very much. 2. The newer drugs are generally more potent & selective, and formulations becoming increasingly complex. 3. The literature on drugs has also expanded and covers a wide range of information. 4. To introduce a new drug into the practice, the professionals need to evaluate the given information. 5. A simple, quick reference to a pharmacopoeia or formulary is no longer sufficient. Aims and objectives of drug information services. 6. The provision of information to health professionals on specific problems related to the use of drugs in particular patients. 7. The provision of information to officials in government agencies to optimize the decision making process. DEFINITIONS, DEVELOPMENT AND SCOPE OF CLINICAL PHARMACY
PHARMD GURU Page 2 8. The preparation and development of guidelines and formularies. 9. To improve patient compliance and to provide a guide to responsible self-medication; 10. To develop and participate in continuing education programs. 11.To participate in undergraduate and graduate teaching programs. 12.To develop educational activities regarding the appropriate use of drugs for patients in the community. 13.To prepare and distribute material on drugs to health personnel in the form of a drug Information bulletin and/or other media. 14.To develop and participate in research programs. The Sources of information/Resources available: 1. Primary Source: • Information is presented by authors without any evaluation by a second party. • Provides must current information about drugs. Examples; articles published in journals (e.g. British Medical Journal), thesis etc 2. Secondary source: • The original source has been evaluated by second party other than the publisher. • Modified and rearranged form Examples; review articles like LexisNexis, Medline etc. 3. Tertiary source: • Information obtained from primary and secondary source and arranged in a manner to represent a composite of the available information. Examples; Representative form Pharmacopoeias - BP, USP, IP, BNF etc., Encyclopaedias, Dictionaries, Guides, text books and Other Sources: a) The DIC also receives information from b) The public and hospitals about the Adverse effects of any drug c) Local drug lists d) National Formularies e) Hospital Formularies

PHARMD GURU Page 4 Step V: Perform evaluation, analysis & synthesis: Provider should take time to evaluate the info, analyse and then synthesize it into a good reply. Step VI: Formulate and provide response: • An outline should be established to help formulate a response to the drug info request. • It‟s important to have; introduction, body and conclusion. Step VII; Conduct follow-up and documentation. • Checking with the requestor to make sure his/her question has been sufficiently and completely answered. • Of vital importance is to document all the steps taken in this process. DRUG LITERATURE EVALUATION: 1. Among the skills of drug information is knowledge of drug literature evaluation which allows one to provide a critical analysis of the literature and have a better understanding of the studies done in health and medicine. 2. It is a key component to provide a good quality answer to a requester. 3. Being able to separate good data from poor data is essential. 4. Knowing the limitations of any study can help in evaluating the usability of its data. 5. Drug information specialists will often use some standard questions to help in this process. 6. Several references provide guides to evaluate the medical and pharmacy literature. GENERAL GUIDELINES FOR RESPONSES TO DRUG INFORMATION: 1. Do not guess 2. Take several ethical issues into account 3. Patient privacy must be maintained 4. Patient-physician relation cannot be breached 5. Response is not necessary if the inquirer intends to misuse or abuse the information that is provided.